Drugs / GP404141
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06497036 | Apr 2023 → Mar 2028 expected | — | Geropharm | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GP404141 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06497036 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT06497036 ↗ |